News

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines

BioCity Biopharmaceutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced that it has entered into a clinical trial collaboration

Caliber recently launched 4 digital solutions that further strengthen its portfolio and also position the company at the forefront of the Pharma 4.0 revolution.

GC Cell, under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005

Lipocine Inc. a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics

Centivax, a biotechnology company that develops broad-spectrum vaccines to combat rapidly evolving pathogens, has announced a strategic collaboration

Glenmark Therapeutics Inc., USA is pleased to announce the launch1 of Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC)

GBM Health Holding, a global leader in integrated healthcare innovation, is proud to announce that its subsidiaries Gene Biotechnology Enterprises Ltd

Moleculin Biotech, Inc. a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses